Evaluation of Risk Factors for Major Amputation in Patients With Diabetes and Peripheral Artery Disease Receiving Antiplatelet Therapy 　- Post Hoc Analysis of a Prospective Observational Multicenter Cohort Study (SEASON).

CONCLUSIONS: These findings inform real-world understanding of PAD in diabetic patients receiving antiplatelet therapy in Japan, and showed that ABI <0.4 was the strongest risk factor for amputation.
PMID: 31292312 [PubMed - as supplied by publisher]

Source: Circulation Journal - July 9, 2019 Category: Cardiology Authors: Higashi Y, Miyata T, Shigematsu H, Origasa H, Fujita M, Matsuo H, Naritomi H, Nakajima M, Yuki S, Awano H Tags: Circ J Source Type: research